Orchard Therapeutics Ends Key Financial Agreement Post-Transaction
Market News

Orchard Therapeutics Ends Key Financial Agreement Post-Transaction

Orchard Therapeutics PLC (ORTX) has released an update to notify the public and investors about a termination of a material definitive agreement.

Upon completing the Transaction, the Company has repaid all outstanding loans and ended all credit commitments under the previously amended Senior Term Facilities Agreement involving the Company, the original guarantors, MidCap Financial (Ireland) Limited, and various lenders.

For further insights into ORTX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyOrchard enters agreement with Beneluxa enabling reimbused access to Libmeldy
GlobeNewswireOrchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
Christine BrownOrchard Therapeutics Announces Board Reshuffle Following Transaction
Go Ad-Free with Our App